Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04783571 · ClinicalTrials.gov registry record · NA

Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia

A NA study of Schizophrenia, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04783571 is a NA study of Schizophrenia that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 70 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04783571, a NA study of Schizophrenia, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The investigators will test the hypothesis that auditory stimulation (playing quiet sounds during sleep) can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance under two conditions separated by one week: receiving auditory stimulation during sleep and not receiving auditory stimulation during sleep. The investigators will study healthy subjects and outpatients with schizophrenia.

Conditions Studied

Interventions

  • OTHER Placebo
  • OTHER Auditory Stimulation

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2020-04-13
Est. Completion 2025-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04783571

The ClinicalTrials.gov registry entry for NCT04783571 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (68% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04783571 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04783571 about?

NCT04783571 is a clinical study titled "Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia". The investigators will test the hypothesis that auditory stimulation (playing quiet sounds during sleep) can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance under two conditions separate...

What is the current status of trial NCT04783571?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2020-04-13. Estimated completion is 2025-12-31.

What conditions does trial NCT04783571 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT04783571?

The interventions under investigation include: Placebo (OTHER), Auditory Stimulation (OTHER).

Who is sponsoring clinical trial NCT04783571?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04783571 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.